Mitral and tricuspid hotline: long-term outcomes

Spokesperson: J. Hausleiter

Discussants: R. Makkar, M. Wild, S. Kapadia, G. Nickenig

Summary

Review long-term outcomes of transcatheter edge-to-edge repair (TEER) for mitral and tricuspid valve disease in this session. Highlights include pivotal trial results, mortality risk prediction tools, management of procedural failures, and real-world data, providing comprehensive insights into patient prognosis and therapeutic impact.

Presentations available when logged in:

Two-year outcomes of Tricuspid TEER for tricuspid regurgitation: the TRILUMINATE pivotal trial
TRI-SCORE for mortality risk prediction after tricuspid valve TEER – the EuroTR registry
Management and outcome of failed tricuspid TEER: the FATE registry
Two-year real-world outcomes for tricuspid TEER: the bRIGHT study
Impact of TEER on prognosis in atrial functional mitral regurgitation

Your free My PCR account will enable you to:

Become a PCR Companion
Access slide presentations from PCR Courses
Watch session videos and LIVE cases
Discuss cases with your peers
Submit and register for PCR Courses
Register for and view PCR Webinars
Read a selection of articles in EuroIntervention
And more…

Mitral and tricuspid hotline: long-term outcomes

Log in or create account for free